High-dose 308-nm excimer laser for the treatment of psoriasis - 01/09/11
Correspondence: Manju Trehan, MD, Department of Dermatology, Massachusetts General Hospital, 55 Fruit St, Bartlett 622, Boston, MA 02114. E-mail: mtrehan@partners.org.
Abstract |
Background: The excimer laser can deliver high-intensity ultraviolet B (UVB) energy at 308 nm, a wavelength similar to that used in narrow-band UVB phototherapy. Objective: The goal of this investigation was to evaluate the role of high-dose single treatments with the excimer 308-nm laser in stable plaque-type psoriasis. Methods: Eighteen volunteers were enrolled in the study. Two plaques were selected and half of each plaque was held as a control while the other half was treated with a single dose of either 8 or 16 times the minimal erythema dose. Results: Sixteen subjects completed the study. Two patients signed up but never actually participated because of scheduling problems. Eleven showed significant improvement within 1 month, and 5 still demonstrated persistent areas of clearing at 4 months. Conclusion: As little as one high-dose excimer laser treatment can be effective for localized plaque-type psoriasis. Multiple treatments or other irradiation schedules with this innovative device may prove even more efficacious. (J Am Acad Dermatol 2002;46:732-7.)
Le texte complet de cet article est disponible en PDF.Plan
Supported by Photomedex, Inc, San Diego, Calif. |
|
Conflicts of interest: None. |
|
Reprints not available from authors. |
|
Published online February 4, 2002. |
Vol 46 - N° 5
P. 732-737 - mai 2002 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?